Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages now181
Publisher
Oxford University Press (OUP)
Online
2016-09-30
DOI
10.1093/neuonc/now181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
- (2016) Benjamin H. Hinrichs et al. Acta Neuropathologica Communications
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
- (2015) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients
- (2015) Pilar Mur et al. JOURNAL OF NEURO-ONCOLOGY
- Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors
- (2015) Marc C. Chamberlain et al. JOURNAL OF NEURO-ONCOLOGY
- Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial
- (2015) Hendrikus J. Dubbink et al. NEURO-ONCOLOGY
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma
- (2015) Pawel Buczkowicz et al. Frontiers in Oncology
- Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma
- (2014) Benedikt Wiestler et al. ACTA NEUROPATHOLOGICA
- International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
- (2014) David N. Louis et al. BRAIN PATHOLOGY
- Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics
- (2014) Walter Taal et al. JOURNAL OF NEURO-ONCOLOGY
- Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM
- (2014) Pankaj Pathak et al. JOURNAL OF NEURO-ONCOLOGY
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
- (2014) Pawel Buczkowicz et al. NATURE GENETICS
- Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
- (2014) Kathryn R Taylor et al. NATURE GENETICS
- Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
- (2014) Adam M Fontebasso et al. NATURE GENETICS
- Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes
- (2014) M. Labussiere et al. NEUROLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951
- (2013) Thierry Gorlia et al. EUROPEAN JOURNAL OF CANCER
- The next step in brain tumor classification: “Let us now praise famous men”… or molecules?
- (2012) David N. Louis ACTA NEUROPATHOLOGICA
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More